Large international study will help select and categorize patients for better clinical trials
A large multi-centre study of more than 1,200 patients provides important predictors of Parkinson’s disease progression, which will allow better candidate selection for clinical trials and more effective therapy development.
Scientists prove difference between expected/actual outcomes cause reward response
If you love it when a musician strikes that unexpected but perfect chord, you are not alone. New research shows the musically unexpected activates the reward centre of our brains, and makes us learn about the music as we listen.
Researchers seek to answer longstanding debate
Scanner will deliver clear images of the nervous system in exceptional detail
Scientists will see the human nervous system in microscopic detail thanks to the installation of Canada’s first 7-Tesla whole-body magnetic resonance imaging (MRI) scanner on Feb. 5.
Technique involves use of non-invasive digital infrared imaging
Reinhardt lab receives 5-year CIHR grant to investigate extracellular matrix-mediated regulation of microRNAs in health and disease.
Reinhardt lab receives 5-year CIHR grant to investigate extracellular matrix-mediated regulation of microRNAs in health and disease. Congratulations!
Quebec researchers among recipients of $34 million ‘Grand Challenge’ Grant from Cancer Research UK to combat cancer
McGill and MUHC research teams part of an international effort to uncover how chronic inflammation causes cancer
Reducing stigma may address cognitive impairment in this population
A new study has drawn a direct link between the amount of stigma men with HIV report experiencing and their scores on cognitive tests, measuring abilities such as memory and attention.
Concerns raised about efficacy of off-label use of already approved drugs
A new paper published by McGill University researchers in JAMA Internal Medicine suggests that some clinical trials may promote the use of ineffective and costly treatments. That’s the opposite of what clinical trials are aimed at, namely preventing ineffective and costly treatments from being taken up by physicians and patients.
A researcher from the Montreal Neurological Institute and Hospital (The Neuro) is one of eight scientists to receive a grant this year from the ALS Society of Canada.
Source: MUHC Newsroom
For new HPV DNA test, study finds there may be little benefit in screening women aged 55 with a negative testRegular cytology screening (pap or smear test) is still the most commonly used HPV screening method, and can prevent cancers up to age 75 years, although benefits decline with age For the newly introduced HPV DNA test, which offers a higher degree of accuracy, women aged 55 who have a negative test were predicted to be at low risk of cervical cancer
A single negative human papillomavirus (HPV) DNA test – a newly introduced test which can detect c